CINECA IRIS Institutional Research Information System

MAIONE, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.322
EU - Europa 3.481
AS - Asia 3.398
SA - Sud America 300
AF - Africa 81
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.158
IT - Italia 1.454
CN - Cina 1.368
SG - Singapore 976
FR - Francia 312
DE - Germania 290
VN - Vietnam 272
GB - Regno Unito 229
IE - Irlanda 229
BR - Brasile 223
FI - Finlandia 201
SE - Svezia 166
HK - Hong Kong 158
JP - Giappone 148
CA - Canada 116
IN - India 111
AT - Austria 103
KR - Corea 95
PL - Polonia 78
UA - Ucraina 66
ES - Italia 60
NL - Olanda 55
BE - Belgio 48
ID - Indonesia 44
AR - Argentina 43
TW - Taiwan 43
AU - Australia 35
CH - Svizzera 35
IL - Israele 33
RU - Federazione Russa 27
SN - Senegal 27
MX - Messico 26
IQ - Iraq 25
DK - Danimarca 24
ZA - Sudafrica 22
BD - Bangladesh 21
TR - Turchia 19
GR - Grecia 18
PK - Pakistan 17
HU - Ungheria 16
LT - Lituania 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
BA - Bosnia-Erzegovina 10
RO - Romania 10
CO - Colombia 9
AE - Emirati Arabi Uniti 8
MA - Marocco 8
EU - Europa 7
IR - Iran 7
NZ - Nuova Zelanda 7
UZ - Uzbekistan 7
CL - Cile 6
DZ - Algeria 6
JO - Giordania 6
LU - Lussemburgo 6
EG - Egitto 5
NG - Nigeria 5
PT - Portogallo 5
TH - Thailandia 5
AM - Armenia 4
HR - Croazia 4
JM - Giamaica 4
LB - Libano 4
NO - Norvegia 4
PH - Filippine 4
VE - Venezuela 4
AL - Albania 3
CR - Costa Rica 3
KZ - Kazakistan 3
MY - Malesia 3
OM - Oman 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SV - El Salvador 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
IS - Islanda 1
NI - Nicaragua 1
NP - Nepal 1
Totale 12.629
Salva come PNG Salva come JPEG
Città #
Singapore 552
San Jose 413
Beijing 362
Ashburn 361
Chandler 346
Ann Arbor 323
Santa Clara 259
Torino 253
Fairfield 246
Dublin 228
Houston 174
Milan 171
Turin 156
Seattle 123
Woodbridge 118
Shanghai 115
Wilmington 107
Cambridge 103
Los Angeles 102
Dearborn 94
Guangzhou 92
Vienna 92
Helsinki 88
Hong Kong 83
Redwood City 83
Villeurbanne 82
Ho Chi Minh City 76
Rome 76
Nyköping 74
Dallas 71
The Dalles 69
Munich 68
Pisa 66
Tokyo 65
Columbus 64
Jacksonville 61
Princeton 59
Medford 58
Lauterbourg 57
New York 55
Warsaw 55
Hangzhou 53
Hanoi 52
Nanjing 45
Buffalo 41
Jakarta 40
Frankfurt am Main 39
Fremont 38
Hefei 37
Seoul 37
London 36
Boston 35
Dong Ket 33
Boardman 30
Wuhan 30
San Diego 28
San Francisco 28
Brussels 27
Phoenix 27
São Paulo 25
Turku 25
Nuremberg 24
Bengaluru 22
Changsha 21
Chengdu 21
Chicago 20
Montreal 20
Taipei 20
Council Bluffs 19
Palermo 19
Paris 19
Pittsburgh 18
Jinan 17
Tianjin 17
Xian 17
Atlanta 16
Toulouse 15
Chennai 14
Melbourne 14
Orem 14
Shenzhen 14
Silver Spring 14
Zhengzhou 14
Amsterdam 13
Central 13
Chongqing 13
Ottawa 13
Bari 12
Johannesburg 12
Redondo Beach 12
Barcelona 11
Central District 11
Florence 11
Indianapolis 11
Madrid 11
Moscow 11
Norwalk 11
Padua 11
Toronto 11
Washington 11
Totale 7.393
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 2.428
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 871
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 428
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling 314
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. 298
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 272
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. 267
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 260
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 244
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 239
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. 238
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 237
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy 225
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 225
Class 3 semaphorins in cardiovascular development 221
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers 214
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 212
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 186
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 181
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth 179
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 169
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 155
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 155
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 155
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 154
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 153
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 150
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 150
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 144
Squalenic nanoparticles with active targeting: in vivo results 142
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway 136
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 134
Osteopontin binds ICOSL promoting tumor metastasis 134
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 131
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 130
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer 128
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 128
Semaphorins and tumor angiogenesis 117
Increased Expression of {alpha}6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane 117
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 116
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 114
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy 113
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 112
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability 111
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression 106
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner 106
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection 105
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 105
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 103
Targeted nanoparticles for pancreatic cancer. 103
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 99
Design and synthesis of encorafenib-based BRAF-V600E degraders 97
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 96
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition 95
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 93
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 91
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 91
Targeted nanoparticles for pancreatic cancer. 89
Nanoparticles targeting pancreatic tumor. 89
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth 85
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 83
Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator 83
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 81
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 78
Semaphorin 4A-expressing bone marrow-derived myeloid cells promote tumor progression 23
Inhibition of Semaphorin 4A-expressing bone marrow-derived myeloid cells impairs tumor progression in PDAC 12
Totale 12.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.183
article - articoli 0
book - libri 0
conference - conferenze 10.294
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.477
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.322 106 109 85 114 84 100 78 91 79 90 235 151
2022/20231.375 113 124 52 113 119 299 121 84 125 58 102 65
2023/20241.013 85 133 77 91 80 72 75 90 26 73 95 116
2024/20251.995 52 111 140 154 405 152 98 108 199 139 176 261
2025/20263.589 344 165 209 352 330 172 567 134 333 375 147 461
2026/202791 91 0 0 0 0 0 0 0 0 0 0 0
Totale 12.900